Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.

An Expanded Treatment Protocol of Panobinostat Plus Bortezomib and Dexamethasone in Patients With Previously Treated Myeloma.

Vincent L. Hansen,Morton Coleman,Stephanie Elkins,Jeffrey P. Letzer,Moshe Yair Levy,Lasika Seneviratne,Jessica Rine,Marina White,Emil T. Kuriakose

Clinical Lymphoma Myeloma and Leukemia（2018）

Cited 8|Views14
No score
Abstract
Overall, data from the PANEX trial support regulatory approval of panobinostat plus bortezomib and dexamethasone and suggest the potential tolerability benefits of subcutaneous bortezomib in this regimen.
More
Translated text
Key words
Epigenetics,Histone deacetylase inhibitor,PANORAMA,Safety,Subcutaneous BTZ
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined